Nuveen’s Elevation Oncology ELEV Stock Holding History

Nuveen’s Portfolio ELEV Stock Details ELEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-23,913	Closed	-$8.78K	–	3272
2025 Q2	$8.78K	Sell	23,913 -150,224	-86%	-$50.1K	﹤0.01%	3271
2025 Q1	$45.1K	Hold	174,137	–	–	﹤0.01%	3262
2024 Q4	$98K	Hold	174,137	–	–	﹤0.01%	3291
2024 Q3	$104K	Buy	174,137 +92,950	+114%	+$138K	﹤0.01%	3305
2024 Q2	$219K	Buy	+81,187	New	+$306K	﹤0.01%	3200

Other funds holding ELEV

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Nuveen's ELEV Position: Q3 2025 in Review

Nuveen sold out of Elevation Oncology (ELEV) in Q3 2025, closing a stake of 23,913 shares — an estimated $8.78K sold.

Nuveen first reported a position in ELEV in Q2 2024 and held it in 5 quarters. The position peaked at $219K in Q2 2024. 1 fund tracked by Wall St. Rank holds ELEV as of Q3 2025.

Nuveen reported no remaining Elevation Oncology position as of Q3 2025 after selling out during the quarter.
Nuveen sold 23,913 Elevation Oncology shares in Q3 2025, an estimated $8.78K.
Nuveen first reported a position in Elevation Oncology in Q2 2024 and held it in 5 quarters.
Nuveen's Elevation Oncology position peaked at $219K in Q2 2024.
1 fund tracked by Wall St. Rank held Elevation Oncology as of Q3 2025.

Based on Nuveen's 13F filing for Q3 2025, filed 12 Nov 2025.